Evoke Pharma, Inc.

EVOK

Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for rare and underserved diseases. Its primary product is Gimoti, an oral solution for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company aims to address unmet medical needs through innovative drug formulations and targeted therapies.

$10.93 -0.01 (-0.09%)
🚫 Evoke Pharma, Inc. does not pay dividends

Company News

Halper Sadeh LLC Encourages EVOK, FSFG, BRY Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. • Halper Sadeh Llc • December 2, 2025

Law firm investigating potential securities law violations and fiduciary duty breaches for three companies undergoing mergers or acquisitions.

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE
Benzinga • Juan Monteverde • November 13, 2025

Law firm Monteverde & Associates is investigating potential legal actions related to merger transactions involving Huntington Bancshares, Avadel Pharmaceuticals, Evoke Pharma, and trueCar.

Biotech Penny Stocks Investing Guide
PennyStocks • J. Phillip • June 20, 2022

What to know about trading biotech stocks in 2022 The post Biotech Penny Stocks Investing Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Related Companies